WOONSOCKET, R.I. - CVS Health (NYSE: CVS )周一宣布，其董事会已批准对公司普通股每股派发0.665美元的季度股息。 根据这家医疗保健公司的新闻声明，该股息将于2025年8月1日支付给截至2025年7月22日的在册股东。

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The ...

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

Investing.com - TD Cowen维持了对CVS Health (NYSE: CVS )的买入评级和95.00美元的目标价，表示该公司可能从Centene (NYSE: CNC )面临的挑战中受益。根据 InvestingPro 数据，Centene目前的市盈率为5.23，分析师目标价在45美元至92美元之间，反映了市场在当前挑战下的复杂情绪。

2025年7月1日，药品零售公司西维斯（CVS）成交额为3.29亿美元，在当日美股中排第293名，成交额较昨日减少20.99%，当日成交量为472.45万。 西维斯（CVS）于2025年7月1日涨0.86%，报69.57美元，该股过去5个交易日涨2.94%，整个7月涨0.86%，年初至今涨54.98%，过去52周涨19.64%。 *如果公司上市时间少于52周，则52周涨跌幅为上市至今涨跌幅（同样适 ...

This action was surfaced by Law.com Radar, which delivers real-time alerting on new litigation across more than 2,900 state ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

Shares of CVS Health are trading higher Thursday afternoon. The stock is climbing after a GOP healthcare bill hit a roadblock ...

In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, ...